Thierry Laugel, Kurma Partners' co-founder and Managing Director, emphasizes that "Access to exceptional science and the best industry capabilities is at the heart of what we do." This reflects the company's mission to enhance the European health innovation ecosystem.
Rémi Droller, MD of Kurma Partners, expresses excitement about Biofund IV, stating, "We are excited with the launch of Biofund IV and confident that we will continue to generate positive returns for investors and make a real impact for human health."
The fund aims to make 16 to 20 investments and has already committed to three companies, emphasizing a strategy focused on supporting both company creation and established ventures.
Kurma Partners plans to leverage its collaborative approach with academic scientists and industry professionals to ensure the success of portfolio companies, mirroring successful strategies used in their previous fund, Biofund III.
Collection
[
|
...
]